Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

549.16
+16.383.07%
Volume:577.86K
Turnover:315.99M
Market Cap:23.55B
PE:19.65
High:551.15
Open:528.92
Low:528.92
Close:532.78
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.52
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.68
PE(LYR):19.71

Loading ...

United Therapeutics CEO Martine A. Rothblatt Disposes of USD 3.94 Million in Common Shares

Reuters
·
Sep 11

United Therapeutics Announces New Accelerated Share Repurchase

TIPRANKS
·
Sep 09

United Therapeutics CEO Martine Rothblatt Disposes of Common Shares Worth $4.64 Million

Reuters
·
Sep 09

United Therapeutics to Repurchase $478 Million of Shares

MT Newswires Live
·
Sep 08

United Therapeutics Corporation - Final Settlement of Asr Expected in Q4 2026

THOMSON REUTERS
·
Sep 08

United Therapeutics Corporation - to Pay $477.60 Mln to Citi on or Around Sept 10, 2026

THOMSON REUTERS
·
Sep 08

United Therapeutics Corporation - to Receive Initial Delivery of 75% of Repurchased Shares Based on Sept 8, 2026 Price

THOMSON REUTERS
·
Sep 08

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization

THOMSON REUTERS
·
Sep 08

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,406 Common Shares Worth $4.64 Million

Reuters
·
Sep 04

Wells Fargo Reaffirms Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
Sep 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and Medtronic (MDT)

TIPRANKS
·
Sep 02

United Therapeutics Says FDA Accepts Tyvaso sNDA for Idiopathic Pulmonary Fibrosis Review

Reuters
·
Sep 02

United Therapeutics Corporation - FDA Review Expected to be Complete in Late April 2027

THOMSON REUTERS
·
Sep 02

United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Sep 02

United Therapeutics Chairperson, CEO Rothblatt Disposes of Common Shares Worth $4.85 Million

Reuters
·
Sep 02

United Therapeutics Executives to Speak at Wells Fargo Healthcare Investor Conference

Reuters
·
Sep 01

United Therapeutics (UTHR) Will Present Phase 3 Data At European Congresses

Simply Wall St.
·
Aug 30

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of 7,500 Common Shares for $3.93 Million

Reuters
·
Aug 29

United Therapeutics Submits FDA NDA for PAH Drug Ralinepag

Reuters
·
Aug 28

RBC Capital Sticks to Its Buy Rating for United Therapeutics (UTHR)

TIPRANKS
·
Aug 27